Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide for Prevention of Hepatic VOD in HSCT
NCT02851407Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Sep 2016
- Primary completion
- Oct 2020
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of defibrotide in hepatic veno-occlusive disease (HVOD), sponsored by Jazz Pharmaceuticals plc. Started Sep 2016; status: completed.
02
Drugs
defibrotide
03
Conditions
hepatic veno-occlusive disease (HVOD)
Beyond the preview
Go deeper on NCT02851407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851407.